Miyazaki, K.; Fujii, T.; Mori, K.; Tamimoto, R.; Nagamatsu, H.; Murakami, T.; Cho, Y.; Goto, S.; Mori, H.
Sustained Myocarditis following Messenger RNA Vaccination against Coronavirus Disease 2019: Relation to Neutralizing Antibody and Amelioration by Low-Dose Booster Vaccination. J. Clin. Med. 2023, 12, 1421.
https://doi.org/10.3390/jcm12041421
AMA Style
Miyazaki K, Fujii T, Mori K, Tamimoto R, Nagamatsu H, Murakami T, Cho Y, Goto S, Mori H.
Sustained Myocarditis following Messenger RNA Vaccination against Coronavirus Disease 2019: Relation to Neutralizing Antibody and Amelioration by Low-Dose Booster Vaccination. Journal of Clinical Medicine. 2023; 12(4):1421.
https://doi.org/10.3390/jcm12041421
Chicago/Turabian Style
Miyazaki, Koji, Toshiharu Fujii, Kikue Mori, Ryuichi Tamimoto, Hirofumi Nagamatsu, Tsutomu Murakami, Yasunori Cho, Shinya Goto, and Hidezo Mori.
2023. "Sustained Myocarditis following Messenger RNA Vaccination against Coronavirus Disease 2019: Relation to Neutralizing Antibody and Amelioration by Low-Dose Booster Vaccination" Journal of Clinical Medicine 12, no. 4: 1421.
https://doi.org/10.3390/jcm12041421
APA Style
Miyazaki, K., Fujii, T., Mori, K., Tamimoto, R., Nagamatsu, H., Murakami, T., Cho, Y., Goto, S., & Mori, H.
(2023). Sustained Myocarditis following Messenger RNA Vaccination against Coronavirus Disease 2019: Relation to Neutralizing Antibody and Amelioration by Low-Dose Booster Vaccination. Journal of Clinical Medicine, 12(4), 1421.
https://doi.org/10.3390/jcm12041421
